Alain Gelibter, MD, PhD
Department of Medical Oncology, Policlinico Umberto I, Sapienza University of Rome, Rome, Italy
Research Interests: cancer, oncology, immunotherapy, NSCLC, colorectal cancer, lung cancer, pancreatic cancer, targeted therapy, molecular target, smart molecules, new drugs, phase I-III studies, cancer patient management
Alain Gelibter 48 years old, Board in Medical Oncology in 2003 with 70/70 cum laude and PhD in molecular Medicine at Sapienza University of Rome. Dr. Gelibter is a senior staff member at “Department of Medical Oncology” Policlinico Umberto I Hospital, Sapienza University of Rome (Italy). He is also principal or sub-investigator in Phase I-III oncologic trials and author of more than 60 articles published on PubMed. He has been speaker at major national and international congress, as well as member of Lung and GI unit at Policlinico Umberto I Hospital, Sapienza University of Rome, and Effective Member of Italian Association of Medical Oncology (AIOM).
Editorial Board
Terms of Appointment: September 2021 - August 2023